Pharmaceuticals

Global Insights: Cancer Immunotherapy Market Expected to Surpass $189.5 Billion by 2029

August 21, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Large Is the Cancer Immunotherapy Market Expected to Be in 2029?#_x000D_

The size of the cancer immunotherapy market has seen swift expansion in the last few years. Predicted to escalate from a valuation of $110.91 billion in 2024 to $124.09 billion in 2025, it’s expected to experience a compound annual growth rate (CAGR) of 11.9%. Factors contributing to the growth experienced during the historical period include a rising incidence of cancer, greater inclination toward immunotherapy instead of conventional therapies, burgeoning research and development efforts targeting specific diseases, improved effectiveness and precision of recently-developed therapies, and increasing acknowledgment of the drawbacks associated with traditional cancer treatments._x000D_

_x000D_

The market size for cancer immunotherapy is predicted to experience swift expansion in the approaching years. The value is set to rise at a compound annual growth rate (CAGR) of 11.2%, reaching $189.5 billion by 2029. This anticipated upsurge during the forecast period is largely due to the rising approvals of innovative immunotherapies for cancer cure, swelling demand for tailored medicine, climbing instances of cancer diagnoses, escalating investment in clinical studies for new treatment methods, and heightened awareness about cancer immunotherapy. The projection period will witness several prominent trends, such as increasing implementation of adoptive cell therapies, notably car-t cells, leveraging oncolytic viruses in cancer immunotherapy, the advancement of bespoke cancer vaccines, the application of artificial intelligence in research on immunotherapy, and a growing focus on real-world evidence and patient results when making treatment plans._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp_x000D_

_x000D_

#What Are The Contributors To Demand In The Cancer Immunotherapy Market?#_x000D_

The anticipated surge in cancer occurrences is predicted to stimulate the cancer immunotherapy market. Tobacco, alcohol, obesity, inactive lifestyle, and ecological factors are all contributing to the worldwide increase in cancer incidents. This surge is projected to augment the demand for cancer immunotherapies, as patients are showing a tendency to invest in medical procedures that offer higher recuperation and minimal discomfort. For example, information from the European Union Science Hub, a Joint Research Centre of the Belgium-based European Commission, revealed a 2.3% increase in new cancer cases over the previous two years, hitting 2.74 million in 2022. In the same period, cancer deaths also rose by 2.4%. Consequently, the upward trend in cancer occurrences is anticipated to increase the demand for cancer immunotherapy throughout the prediction period._x000D_

_x000D_

#What Segmentation Categories Are Included In The Cancer Immunotherapy Market Analysis?#_x000D_

The cancer immunotherapy market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy_x000D_

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma_x000D_

3) By End User: Hospitals, Cancer Research Centers, Clinics_x000D_

_x000D_

Subsegments:_x000D_

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies_x000D_

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors_x000D_

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists_x000D_

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines_x000D_

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy_x000D_

_x000D_

#What Upcoming Trends Are Expected To Impact The Cancer Immunotherapy Market Globally?#_x000D_

The increasing use of advanced technologies in cancer immunotherapy is a key emerging trend in the cancer immunotherapy market. A raft of new technologies and therapies designed to help the immune system recognize and combat tumors has been introduced, including immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These breakthroughs could significantly impact the treatment and potential eradication of cancer. For example, in October 2022, the UK-based pharmaceutical and biotech company, AstraZeneca Plc, announced that they had obtained approval for their Capivasertib in conjunction with Faslodex. This immunotherapeutic cancer drug is designed to treat breast cancer effectively, particularly in the event of recurrence or progression following endocrine therapy for locally advanced or metastatic breast cancer with low or negative human epidermal growth factor receptor 2 (HER2)._x000D_

_x000D_

#Who Are The Top-Ranked Companies In The Cancer Immunotherapy Market Today?#_x000D_

Major companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report_x000D_

_x000D_

#How Is Cancer Immunotherapy Market Adoption Varying Across Different Regions And Sectors?#_x000D_

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_